Effetti metabolici e cardiovascolari della terapia antiretrovirale combinata in pazienti con infezione da HIV. Rassegna sistematica della letteratura.

Translated title of the contribution: [Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature].

Laura Casaretti, Stefania Paolillo, Roberto Formisano, Ada Bologna, Giacomo Mattiello, Sirio Conte, Laura Petraglia, Francesco Lo Ludice, Irma Fabiani, Anna Paola Cirillo, Alice Vitagliano, Francesco Gambardella, Giuseppe Luca della Ratta, Pasquale Perrone Filardi

Research output: Contribution to journalArticle

Abstract

In HIV infected patients an increased incidence of cardiac events has been reported since the introduction of highly active antiretroviral therapy (HAART). Antiretroviral drugs' regimens are, in fact, associated with several metabolic side effects, such as dyslipidemia, impaired glucose metabolism and abnormal body fat distribution, that increase cardiovascular risk of HIV subjects. In addition, HIV infection itself, the chronic inflammatory status and the frequent presence in this population of traditional risk factors contribute to an higher incidence of cardio and cerebrovascular events. In last years several studies showed the occurrence of carotid vascular impairment in patients treated with protease inhibitors (PI). Similarly the DAD Study reported an increase of 26% of the risk of myocardial infarction in patients on HAART and that this risk was independently associated with longer exposure to PI, after multivariate adjustments. A correct evaluation of the metabolic status before starting HAART and an adequate control of drugs-related metabolic abnormalities may reduce the incidence of cardiac events and still improve HIV patients prognosis. This review will focus on the metabolic effects of antiretroviral drugs and on the contribution of combination antiretroviral therapy on cardiovascular risk.

Original languageItalian
Pages (from-to)175-182
Number of pages8
JournalMonaldi Archives for Chest Disease - Cardiac Series
Volume76
Issue number4
Publication statusPublished - Dec 2011

Fingerprint

HIV Infections
Highly Active Antiretroviral Therapy
HIV
Protease Inhibitors
Incidence
Body Fat Distribution
Drug and Narcotic Control
Therapeutics
Dyslipidemias
Pharmaceutical Preparations
Blood Vessels
Myocardial Infarction
Glucose
Population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Effetti metabolici e cardiovascolari della terapia antiretrovirale combinata in pazienti con infezione da HIV. Rassegna sistematica della letteratura. / Casaretti, Laura; Paolillo, Stefania; Formisano, Roberto; Bologna, Ada; Mattiello, Giacomo; Conte, Sirio; Petraglia, Laura; Lo Ludice, Francesco; Fabiani, Irma; Cirillo, Anna Paola; Vitagliano, Alice; Gambardella, Francesco; della Ratta, Giuseppe Luca; Filardi, Pasquale Perrone.

In: Monaldi Archives for Chest Disease - Cardiac Series, Vol. 76, No. 4, 12.2011, p. 175-182.

Research output: Contribution to journalArticle

Casaretti, L, Paolillo, S, Formisano, R, Bologna, A, Mattiello, G, Conte, S, Petraglia, L, Lo Ludice, F, Fabiani, I, Cirillo, AP, Vitagliano, A, Gambardella, F, della Ratta, GL & Filardi, PP 2011, 'Effetti metabolici e cardiovascolari della terapia antiretrovirale combinata in pazienti con infezione da HIV. Rassegna sistematica della letteratura.', Monaldi Archives for Chest Disease - Cardiac Series, vol. 76, no. 4, pp. 175-182.
Casaretti, Laura ; Paolillo, Stefania ; Formisano, Roberto ; Bologna, Ada ; Mattiello, Giacomo ; Conte, Sirio ; Petraglia, Laura ; Lo Ludice, Francesco ; Fabiani, Irma ; Cirillo, Anna Paola ; Vitagliano, Alice ; Gambardella, Francesco ; della Ratta, Giuseppe Luca ; Filardi, Pasquale Perrone. / Effetti metabolici e cardiovascolari della terapia antiretrovirale combinata in pazienti con infezione da HIV. Rassegna sistematica della letteratura. In: Monaldi Archives for Chest Disease - Cardiac Series. 2011 ; Vol. 76, No. 4. pp. 175-182.
@article{8230eba432374ec79702dc3bdaef8610,
title = "Effetti metabolici e cardiovascolari della terapia antiretrovirale combinata in pazienti con infezione da HIV. Rassegna sistematica della letteratura.",
abstract = "In HIV infected patients an increased incidence of cardiac events has been reported since the introduction of highly active antiretroviral therapy (HAART). Antiretroviral drugs' regimens are, in fact, associated with several metabolic side effects, such as dyslipidemia, impaired glucose metabolism and abnormal body fat distribution, that increase cardiovascular risk of HIV subjects. In addition, HIV infection itself, the chronic inflammatory status and the frequent presence in this population of traditional risk factors contribute to an higher incidence of cardio and cerebrovascular events. In last years several studies showed the occurrence of carotid vascular impairment in patients treated with protease inhibitors (PI). Similarly the DAD Study reported an increase of 26{\%} of the risk of myocardial infarction in patients on HAART and that this risk was independently associated with longer exposure to PI, after multivariate adjustments. A correct evaluation of the metabolic status before starting HAART and an adequate control of drugs-related metabolic abnormalities may reduce the incidence of cardiac events and still improve HIV patients prognosis. This review will focus on the metabolic effects of antiretroviral drugs and on the contribution of combination antiretroviral therapy on cardiovascular risk.",
author = "Laura Casaretti and Stefania Paolillo and Roberto Formisano and Ada Bologna and Giacomo Mattiello and Sirio Conte and Laura Petraglia and {Lo Ludice}, Francesco and Irma Fabiani and Cirillo, {Anna Paola} and Alice Vitagliano and Francesco Gambardella and {della Ratta}, {Giuseppe Luca} and Filardi, {Pasquale Perrone}",
year = "2011",
month = "12",
language = "Italian",
volume = "76",
pages = "175--182",
journal = "Monaldi Archives for Chest Disease",
issn = "1122-0643",
publisher = "Fondazione Salvatore Maugeri",
number = "4",

}

TY - JOUR

T1 - Effetti metabolici e cardiovascolari della terapia antiretrovirale combinata in pazienti con infezione da HIV. Rassegna sistematica della letteratura.

AU - Casaretti, Laura

AU - Paolillo, Stefania

AU - Formisano, Roberto

AU - Bologna, Ada

AU - Mattiello, Giacomo

AU - Conte, Sirio

AU - Petraglia, Laura

AU - Lo Ludice, Francesco

AU - Fabiani, Irma

AU - Cirillo, Anna Paola

AU - Vitagliano, Alice

AU - Gambardella, Francesco

AU - della Ratta, Giuseppe Luca

AU - Filardi, Pasquale Perrone

PY - 2011/12

Y1 - 2011/12

N2 - In HIV infected patients an increased incidence of cardiac events has been reported since the introduction of highly active antiretroviral therapy (HAART). Antiretroviral drugs' regimens are, in fact, associated with several metabolic side effects, such as dyslipidemia, impaired glucose metabolism and abnormal body fat distribution, that increase cardiovascular risk of HIV subjects. In addition, HIV infection itself, the chronic inflammatory status and the frequent presence in this population of traditional risk factors contribute to an higher incidence of cardio and cerebrovascular events. In last years several studies showed the occurrence of carotid vascular impairment in patients treated with protease inhibitors (PI). Similarly the DAD Study reported an increase of 26% of the risk of myocardial infarction in patients on HAART and that this risk was independently associated with longer exposure to PI, after multivariate adjustments. A correct evaluation of the metabolic status before starting HAART and an adequate control of drugs-related metabolic abnormalities may reduce the incidence of cardiac events and still improve HIV patients prognosis. This review will focus on the metabolic effects of antiretroviral drugs and on the contribution of combination antiretroviral therapy on cardiovascular risk.

AB - In HIV infected patients an increased incidence of cardiac events has been reported since the introduction of highly active antiretroviral therapy (HAART). Antiretroviral drugs' regimens are, in fact, associated with several metabolic side effects, such as dyslipidemia, impaired glucose metabolism and abnormal body fat distribution, that increase cardiovascular risk of HIV subjects. In addition, HIV infection itself, the chronic inflammatory status and the frequent presence in this population of traditional risk factors contribute to an higher incidence of cardio and cerebrovascular events. In last years several studies showed the occurrence of carotid vascular impairment in patients treated with protease inhibitors (PI). Similarly the DAD Study reported an increase of 26% of the risk of myocardial infarction in patients on HAART and that this risk was independently associated with longer exposure to PI, after multivariate adjustments. A correct evaluation of the metabolic status before starting HAART and an adequate control of drugs-related metabolic abnormalities may reduce the incidence of cardiac events and still improve HIV patients prognosis. This review will focus on the metabolic effects of antiretroviral drugs and on the contribution of combination antiretroviral therapy on cardiovascular risk.

UR - http://www.scopus.com/inward/record.url?scp=84862320351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862320351&partnerID=8YFLogxK

M3 - Articolo

C2 - 22567733

VL - 76

SP - 175

EP - 182

JO - Monaldi Archives for Chest Disease

JF - Monaldi Archives for Chest Disease

SN - 1122-0643

IS - 4

ER -